Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure sustainable patient access to Boehringer Ingelheim’s portfolio of leading ...
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...
Safe to say Chris "Mad Dog" Russo doesn't rank Baltimore Ravens head ... personality and sports analyst ruthlessly mocked CBS's Tony Romo for calling Harbaugh a top-10 coach this past weekend.
Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...
Wednesday, October 16, isn’t Festivus, but it might as well be for Chris “Mad Dog” Russo, who aired his grievances with many sports media figures, including but not limited to Tony Romo ...
Austin comedian Tony Hinchcliffe is facing backlash for making racist remarks about Puerto Ricans during his set at a rally for former President Donald Trump, drawing criticism from high-profile ...
WORCESTER ― After five years on Water Street, Russo Italian Restaurant will permanently close, according to the owner. The restaurant’s last day is Oct. 26, according to a statement posted on ...
University of Virginia men’s basketball coach Tony Bennett, who led the Cavaliers to the 2019 national championship, is retiring, the school confirmed Thursday. Bennett will formally announce ...
AGBO, the media company led by filmmakers Anthony and Joe Russo of Marvel’s “Avengers: Endgame” fame, has hired AI expert Dominic Hughes as its first chief scientific officer. Hughes ...
CHARLOTTESVILLE, Va. — One day after Tony Bennett shocked the college basketball world with news that he would retire just 20 days before his Virginia men’s basketball team is set to open its ...
Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis ...